SEAL™ITSEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

Sponsor:

Galaxy Therapeutics INC

Code:

NCT05831202

Conditions

Intracranial Aneurysm

Eligibility Criteria

Sex: All

Age: 22 - 70+

Healthy Volunteers: Not accepted

Interventions

The SEAL™ Saccular Endovascular Aneurysm Lattice System

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Galaxy Therapeutics INC on 2025-04-11.